Literature DB >> 26622658

A rare gastric neuroendocrine carcinoma coexisting with Brunner's gland adenoma: A case report.

Jian-Ming Wei1, Zi-Zhen Zhang1, Yan-Ying Shen1, Dan-Ping Shen1, Xing-Zhi Ni1.   

Abstract

Gastric neuroendocrine carcinoma (G-NEC) is a rare neoplasm known for its aggressive behavior and poor prognosis. Brunner's gland adenoma (BGA) is a rare benign proliferative lesion that develops most commonly in the duodenum. To the best of our knowledge, no cases of G-NEC coexisting with BGA have previously been reported. The present study therefore reports the first case of G-NEC combined with BGA. A 67-year-old female presented with upper abdominal discomfort. No distant metastases were detected upon pre-operative abdominal computed tomography imaging. The patient underwent a radical distal gastrectomy, D2 lymphadenectomy and Billroth I gastroenterostomy. The resected masses were histologically confirmed to be G-NEC and BGA, respectively. The patient did not receive neoadjuvant or adjuvant chemotherapy or radiotherapy, and remains alive with no evidence of metastasis or recurrence at four years post-surgery.

Entities:  

Keywords:  Brunner's gland adenoma; gastric neuroendocrine carcinoma; prognosis

Year:  2015        PMID: 26622658      PMCID: PMC4533721          DOI: 10.3892/ol.2015.3465

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

Review 1.  Surgical treatment of gastrointestinal neuroendocrine tumors.

Authors:  Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2011-02-01       Impact factor: 3.445

2.  Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma.

Authors:  F Panzuto; M Di Fonzo; E Iannicelli; R Sciuto; C L Maini; G Capurso; M Milione; M S Cattaruzza; M Falconi; V David; V Ziparo; P Pederzoli; C Bordi; G Delle Fave
Journal:  Ann Oncol       Date:  2005-12-19       Impact factor: 32.976

Review 3.  Neuroendocrine tumors of the gastro-entero-pancreatic system.

Authors:  Sara Massironi; Valentina Sciola; Maddalena Peracchi; Clorinda Ciafardini; Matilde Pia Spampatti; Dario Conte
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Rationale for the use of somatostatin analogs as antitumor agents.

Authors:  C Susini; L Buscail
Journal:  Ann Oncol       Date:  2006-06-26       Impact factor: 32.976

5.  Brunner's gland hamartomas: clinical presentation and pathological features of 27 cases.

Authors:  J A Levine; L J Burgart; K P Batts; K K Wang
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

Review 6.  Brunner's gland adenoma of duodenum: a case report and literature review.

Authors:  Yu-Ping Gao; Jian-Shan Zhu; Wen-Jun Zheng
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

7.  Giant Brunner's gland adenoma as an unusual cause of anaemia: report of a case.

Authors:  Ali Coskun; Nazif Erkan
Journal:  Radiol Oncol       Date:  2010-12-31       Impact factor: 2.991

8.  Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma.

Authors:  Chieko Uchiyama; Shigeyuki Tamura; Shinichi Nakatsuka; Atsushi Takeno; Hirofumi Miki; Takashi Kanemura; Shin Nakahira; Rei Suzuki; Ken Nakata; Yutaka Takeda; Takeshi Kato
Journal:  World J Surg Oncol       Date:  2012-06-22       Impact factor: 2.754

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.

Authors:  Marc Mejias; Ester Garcia-Pras; Carolina Tiani; Jaime Bosch; Mercedes Fernandez
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.